Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Science Advances|November 22, 2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigensDaichao Wu, Rui Yin, Guodong Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase SystemDrew C Deniger, Anna Pasetto, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12Shigui Zhu, Benoit J Van den Eynde, Pierre G Coulie, et al.
Human Gene Therapy Methods|July 30, 2014
Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectorsSteven A Feldman, Hui Xu, Mary A Black, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosisJin-Ping Lai, Paul F Robbins, Mark Raffeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigenLuisa Novellino, Nicolina Renkvist, Francesca Rini, et al.
The Journal of Investigative Dermatology|February 14, 2006
Clonal persistence and evolution during a decade of recurrent melanomaEna Wang, Sonia Voiculescu, Isabelle C Le Poole, et al.
Cancer Research|September 18, 2002
Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell functionChristopher E Touloukian, Wolfgang W Leitner, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Science Advances|November 22, 2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigensDaichao Wu, Rui Yin, Guodong Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase SystemDrew C Deniger, Anna Pasetto, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12Shigui Zhu, Benoit J Van den Eynde, Pierre G Coulie, et al.
Human Gene Therapy Methods|July 30, 2014
Use of the piggyBac transposon to create stable packaging cell lines for the production of clinical-grade self-inactivating γ-retroviral vectorsSteven A Feldman, Hui Xu, Mary A Black, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosisJin-Ping Lai, Paul F Robbins, Mark Raffeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2006
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytesLaura A Johnson, Bianca Heemskerk, Daniel J Powell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigenLuisa Novellino, Nicolina Renkvist, Francesca Rini, et al.
The Journal of Investigative Dermatology|February 14, 2006
Clonal persistence and evolution during a decade of recurrent melanomaEna Wang, Sonia Voiculescu, Isabelle C Le Poole, et al.
Cancer Research|September 18, 2002
Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell functionChristopher E Touloukian, Wolfgang W Leitner, Paul F Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Pageof 13